Average Co-Inventor Count = 4.59
ph-index = 17
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Berlex Laboratories, Inc. (48 from 100 patents)
2. Schering Aktiengesellschaft (14 from 1,384 patents)
3. Pharmacopeia Drug Discovery, Inc. (6 from 52 patents)
4. Other (4 from 832,843 patents)
5. Ciba-geigy Corporation (3 from 6,850 patents)
6. Exelixis Patent Company LLC (2 from 13 patents)
7. Exelixis, Inc. (1 from 175 patents)
8. Pharmacopeia Inc. (1 from 101 patents)
9. Berlax Laboratories, Inc. (1 from 1 patent)
73 patents:
1. 8846739 - TGR5 agonists
2. 8785488 - Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesity
3. 7268140 - Piperazine derivatives and their use as anti-inflammatory agents
4. 7176207 - Platelet adenosine diphosphate receptor antagonists
5. 7084142 - Platelet adenosine diphosphate receptor antagonists
6. 7056923 - Platelet adenosine diphosphate receptor antagonists
7. 7026323 - Platelet adenosine diphosphate receptor antagonists
8. 6995156 - Platelet adenosine diphosphate receptor antagonists
9. 6977258 - Piperazine derivatives and their use as anti-inflammatory agents
10. 6972290 - Piperazine derivatives and their use as anti-inflammatory agents
11. 6887865 - N-heterocyclic derivatives as NOS inhibitors
12. 6864263 - N-heterocyclic derivatives as NOS inhibitors
13. 6864368 - N-heterocyclic derivatives as NOS inhibitors
14. 6861424 - Platelet adenosine diphosphate receptor antagonists
15. 6852290 - Multi-well apparatus